Medline MDLN
Medline initiates field action for beds
Item 7.01 Investor disclosure
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001104659-26-117844
- Voluntary field action for Medline Brand beds
- Net sales of affected products: $60 million
- Estimated costs up to $220 million
- Expected to be excluded from Adjusted EBITDA
Written from the 8-K on EDGAR. Check the filing before you rely on it.
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Solventum SOLV public float $13.1B, Jun 30, 2025
- Hologic HOLX public float $13.6B, Mar 29, 2025, over 18 months old
- Align Technology ALGN public float $11.1B, Jun 30, 2025
- West Pharmaceutical Services WST public float $15.7B, Jun 30, 2025
- Baxter International BAX public float $16.0B, Jun 30, 2025
